Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2014
12/17/2014CN104220454A 人源化的嵌合抗因子Bb抗体及其用途 Humanized chimeric anti-factor Bb antibody and uses thereof
12/17/2014CN104220453A 人源化的嵌合抗因子c3抗体及其用途 Humanized antibodies and chimeric anti-Factor c3 use
12/17/2014CN104220095A 肝癌的治疗和/或预防用药物组合物 Liver cancer treatment and / or prevention of a pharmaceutical composition for
12/17/2014CN104220093A 抗体变体及其用途 Antibody variants and uses thereof
12/17/2014CN104220091A 能结合流感血细胞凝集素蛋白的合成肽 Can bind influenza hemagglutinin protein synthetic peptide
12/17/2014CN104220047A 含有生物治疗剂和胍或胍衍生物的水性药物组合物以及包含所述组合物的注射剂 Injections containing biotherapeutics guanidine or guanidine derivative and an aqueous pharmaceutical composition comprising said composition and
12/17/2014CN104212828A 一种重组茯苓免疫调节蛋白wcfip1及其抗体的生产方法 A recombinant Poria immunomodulatory protein wcfip1 and production method of antibodies
12/17/2014CN104212806A Alport综合征新的突变致病基因及其编码蛋白和应用 New pathogenic mutations and genes encoding proteins and application Alport syndrome
12/17/2014CN104212770A 一种抗人FeeRIa亚基单克隆抗体及其应用 An anti-human monoclonal antibody and its application FeeRIa subunit
12/17/2014CN104211814A 用于消耗靶膜蛋白的组合物 For the consumption of the target membrane protein composition
12/17/2014CN104211807A 一种抗两种多肽的单克隆抗体及其制备方法和应用 An anti-two polypeptide monoclonal antibody and its preparation method and application
12/17/2014CN104211806A 一种利用抗原量梯度生产羊抗Cys-C多抗血清的方法 A use amount of antigen production and goat anti-gradient Cys-C antiserum method
12/17/2014CN104211805A 一种利用湖羊生产抗补体c3多抗血清的方法 An anti-Hu sheep production complement c3 method utilizes multi antiserum
12/17/2014CN104211804A 一种抗金黄色葡萄球菌多克隆抗体的制备与应用 Preparation and Application of a Staphylococcus aureus polyclonal antibody against
12/17/2014CN104211803A 一种用于猪细小病毒elisa检测的酶标抗体、制备方法及检测试剂盒 A method for the detection of porcine parvovirus elisa enzyme-labeled antibody, preparation and detection kit
12/17/2014CN104211798A 用于制备lrrc52多克隆抗体的免疫原 Immunogen for the preparation of polyclonal antibodies lrrc52
12/17/2014CN104211787A 用于结核病诊断和预防的蛋白 For TB diagnosis and prevention of protein
12/17/2014CN103319600B 一种人源抗TLR4抗体Fab及其制备方法与应用 A humanized anti-TLR4 antibody Fab and its preparation method and application
12/17/2014CN103288962B 呋喃西林残留标示物氨基脲单克隆抗体及制备方法和应用 Nitrofurazone residue markers semicarbazide monoclonal antibody preparation method and application
12/17/2014CN103275182B 基于弓形虫缓殖子抗原的cd8+t细胞优势表位 Based Toxoplasma gondii antigens Bradyzoite cd8 + t cell epitope
12/17/2014CN102818896B 一种基于特异抗体的硝基化修饰位点的检测方法及特异识别scot硝基化位点的抗体 Nitration antibody detection method modification sites and specific recognition sites scot-nitro a specific antibody-based
12/17/2014CN102482355B 抗体 Antibody
12/17/2014CN102227445B 结合丙型肝炎病毒的包膜蛋白2的抗体以及利用所述抗体鉴定丙型肝炎病毒的基因型的方法 Binding of hepatitis C virus envelope protein antibody and genotype 2 method using the antibody identification of hepatitis C virus
12/16/2014US8912385 Rapid production of monoclonal antibodies
12/16/2014US8912314 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
12/16/2014US8912311 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
12/16/2014US8912011 Antibodies to sulfated carbohydrates
12/16/2014US8911964 Fed-batch method of making human anti-TNF-alpha antibody
12/16/2014US8911956 Methods of use for an immunoassay detecting fragment Ba
12/16/2014US8911954 Polypeptide linker and method of analyzing target material using the same
12/16/2014US8911950 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
12/16/2014US8911768 Methods for treating retinopathy with extended therapeutic effect
12/16/2014US8911744 Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
12/16/2014US8911741 Formulation of human antibodies for treating TNF-alpha associated disorders
12/16/2014US8911740 Pharmaceutical composition for treating and/or preventing cancer
12/16/2014US8911739 Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
12/16/2014US8911738 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
12/16/2014US8911737 Methods of administering anti-TNFα antibodies
12/16/2014US8911735 Complement inhibitors and uses thereof
12/16/2014US8911734 Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
12/16/2014US8911733 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
12/16/2014US8911732 Anti-mesothelin antibodies and immunoconjugates
12/16/2014US8911731 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof
12/16/2014US8911730 Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity
12/16/2014US8911729 Stem cell factor inhibitor
12/16/2014US8911728 High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins
12/16/2014US8911727 Monoclonal antibody against human non-small cell lung carcinoma and use thereof
12/16/2014US8911726 Stabilized human Igg4 antibodies
12/11/2014US20140366225 Endogenous Regulator of RNA Silencing in Plants
12/11/2014US20140364592 Cytotoxic immunoglobulin
12/11/2014US20140364591 Psca: prostate stem cell antigen and uses thereof
12/11/2014US20140364590 Dll3 modulators and methods of use
12/11/2014US20140364481 Rna chimeras in human leukemia and lymphoma
12/11/2014US20140364340 Rationally designed, synthetic antibody libraries and uses therefor
12/11/2014US20140364327 Compositions and Methods for the Systemic Treatment of Arthritis
12/11/2014US20140363887 Dll3 modulators and methods of use
12/11/2014US20140363873 Compositions and methods for the diagnosis and treatment of tumor
12/11/2014US20140363845 Cholesterol-based media supplements for cell culture
12/11/2014US20140363832 Molecular marker for the early detection of malignant pleural mesothelioma and the methods of its expression analysis using blood and pleural effusion samples
12/11/2014US20140363494 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N-GLYCOLYL GANGLIOSIDE (NeuGcGM3)
12/11/2014US20140363451 Anti-FOLR1 Immunoconjugate Dosing Regimens
12/11/2014US20140363450 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
12/11/2014US20140363449 Methods, assays, and systems relating to sakt
12/11/2014US20140363448 Cdcp1 and breast cancer
12/11/2014US20140363447 Protofibril-Binding Antibodies And Their Use In Therapeutic And Diagnostic Methods For Parkinson's Disease, Dementia With Lewy Bodies And Other Alpha-Synucleinopathies
12/11/2014US20140363445 Method of treating cancer comprising a vegf-b antagonist
12/11/2014US20140363444 Anti-IL-23 Antibodies
12/11/2014US20140363442 Therapeutic cd47 antibodies
12/11/2014US20140363441 Compositions and methods for the therapy and diagnosis of influenza
12/11/2014US20140363440 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
12/11/2014US20140363439 Anti-lrp6 antibodies
12/11/2014US20140363438 Neuregulin antibodies and uses thereof
12/11/2014US20140363435 Klotho beta
12/11/2014US20140363434 Binding agents to intracellular target molecules
12/11/2014US20140363433 Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
12/11/2014US20140363432 Vascular endothelial cell growth factor antagonists and uses thereof
12/11/2014US20140363431 Methods for treating progressive multiple sclerosis
12/11/2014US20140363430 Activatable Antibodies that Bind Interleukin-6 Receptor and Methods of Use Thereof
12/11/2014US20140363429 Binding molecules specific for her3 and uses thereof
12/11/2014US20140363428 THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE
12/11/2014US20140363427 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
12/11/2014US20140363426 Heterodimeric proteins
12/11/2014US20140363424 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant
12/11/2014US20140363422 Method of providing monoclonal auto-antibodies with desired specificity
12/11/2014US20140363372 Methods for suppressing cancer by inhibition of tmcc3
12/10/2014CN104204808A 脓毒血症和全身炎症反应综合征的诊断 Diagnosis of sepsis syndrome and systemic inflammatory response
12/10/2014CN104204217A 抗cd20抗体利妥昔单抗的稳定化 Anti-cd20 antibody rituximab stabilization
12/10/2014CN104204204A 抗体的Fc区变异体 Fc region of the antibody variants
12/10/2014CN104203981A 双特异性抗体分子 Bispecific antibody molecule
12/10/2014CN104203980A 抗-大-内皮素-1(big-et-1)抗体及其用途 Anti - big - endothelin -1 (big-et-1) antibody and uses thereof
12/10/2014CN104203979A 用于动脉瘤的治疗或预防的方法和药物组合物 A method for the treatment or prevention of aneurysm, and pharmaceutical compositions
12/10/2014CN104203978A 针对硬化蛋白的免疫结合剂 Immunity against sclerostin binding agent
12/10/2014CN104203977A 结合肽聚糖识别蛋白1的抗体 Antibody binding peptidoglycan recognition protein 1
12/10/2014CN104203976A 艰难梭状芽孢杆菌毒素的人源抗体 Clostridium difficile toxin humanized antibody
12/10/2014CN104203975A 用于预测、检测和减少涉及免疫球蛋白单可变结构域的测定法中的非特异性蛋白干扰的技术 Techniques for predicting, detecting and reducing relates immunoglobulin single variable domains of non-specific assay interference protein
12/10/2014CN104203282A 稳定的水性抗体组合物 Stable aqueous antibody composition
12/10/2014CN104203281A 胆囊癌的治疗和/或预防用药物组合物 Gallbladder cancer treatment and / or prevention of a pharmaceutical composition
12/10/2014CN104203092A 病原体和物质陷阱 Trap pathogens and substances
12/10/2014CN104202971A 表达包含V<sub>L</sub>结构域的重链的人源化啮齿动物 People express contains V <sub> L </ sub> domain of the heavy chain of the humanized rodents
12/10/2014CN104195166A 植物通过表达非哺乳动物糖基转移酶而表现出哺乳动物类型的糖基化作用 Plants by expressing non-mammalian glycosyltransferase exhibit glycosylation of mammalian type
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 1494